A Study of Zalifrelimab and Balstilimab for Treatment of Participants With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)
Clinical trial NCT03495882 · COMPLETED
Trial details
- NCT number
- NCT03495882
- Sponsor
- Agenus Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2022-07-15
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.